Most people with SCD seem to meet or exceed current level of physical activity recommendations for the general population, a ...

Columnist Oluwatosin Adesoye shares her thoughts about the role of World Sickle Cell Day in promoting sickle cell awareness.

BEAM-101, a treatment for sickle cell disease, showed sustained efficacy and safety over one year in the BEACON Phase 1/2 ...

Michela Luciano is a Science Writer at BioNews. Originally from the picturesque mountain town of L’Aquila, Italy, Michela ...

The BEACON trial (NCT05456880), which began dosing last year, is evaluating the safety and efficacy of BEAM-101 in people with severe SCD, ages 18-35, who have had at least four VOCs in the two years ...

Illuminating public buildings in red, candlelight vigils, and walks are among events planned for World Sickle Cell Day, June ...

In honor of this year's World Sickle Cell Day, columnist Dunstan Nicol-Wilson recognizes several organizations that are making a difference.

Columnist Mary Shaniqua shares the benefits of attending the European Hematology Association's 2025 Congress as a sickle cell patient.